Canakinumab slightly reduces MI risk in patients with previous MI, but not mortality

Canakinumab slightly reduces MI risk in patients with previous MI, but not mortality is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Canakinumab slightly reduces MI risk in patients with previous MI, but not mortality ID - 1314368 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314368/all/Canakinumab_slightly_reduces_MI_risk_in_patients_with_previous_MI__but_not_mortality PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -